611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Pool Chemicals Harm Thousands Every SummerAre Diets High in Processed Foods a Recipe for Obesity?Lupus Takes Bigger Toll on Longevity for BlacksScientists Spot Unexpected Player in FibromyalgiaAnthrax Is a Risk on Every ContinentAHA News: More Clues to the Genetics Behind an Inherited Cholesterol DisorderSuspect Your Child Has an Ear Infection? There May Soon Be an App for ThatLyme Disease Now a Threat in City Parks Health Tip: Treating a Charley HorseMore Back-to-Back Heat Waves Will Come With Climate ChangeParents, Here's How to Protect Your Child During Measles OutbreaksAHA News: Dangerous Blood Clots May Be the Latest Risk From 'Bad' CholesterolAre You Running Short on Iron?1 in 4 American Workers Struggles With Back PainInjured Lungs Can Be Regenerated for Transplant: StudyKeeping Your Summer Fun on Sound FootingMore Active Lupus Linked to Childhood EventsSigns of Rheumatoid Arthritis Can Show Up Long Before DiagnosisSummer Is Tough for Asthma SufferersHepatitis A Infections Soaring: CDCIs the County You Call Home a Potential Measles Hotspot?'Zap' Ear Clip May Ease A-FibTake Steps to Prevent a StrokeDoes Removing Your Appendix Put You at Risk for Parkinson's?Potentially Blinding Shingles of the Eye on the RisePsoriasis, Mental Ills Can Go Hand in HandAfter Concussions, Some Ex-Athletes Show Key Marker for Brain Disease: StudyWindow for Safe Use of Clot-Buster Widens for Stroke PatientsAn Antibiotic Alternative? Using a Virus to Fight BacteriaDo Adults Need a Measles Booster Shot?Military Tourniquets Might Save Kids' Lives During School ShootingsWell Water's Spillover Effect: Heart Damage?AHA News: Helping Asian-Americans Fight Their Hidden Heart RisksSunscreen Chemicals Enter Bloodstream at Potentially Unsafe Levels: Study'Ringing in the Ears' May Drive Some to the Brink of SuicideBlood Test Might Diagnose Chronic Fatigue SyndromeAsthma Inhalers Incorrectly Used by Most Kids in StudyDevice Helps Doctors Select Lungs for TransplantBenlysta Approved for Children With LupusIn a World First, Drone Delivers Kidney for TransplantHigh Measles Rates Mean Kids, Adults Need Proper Vaccination: CDCParents, Protect Your Kids as Measles Outbreaks SpreadWork Stress, Poor Sleep, High Blood Pressure a Deadly TrioFor Obese People, Commuting by Car Can Be a Killer: StudyHealth Tip: Tick RemovalHalf of Older Dialysis Patients Die Within a Year, Study FindsIs Peanut Allergy 'Immunotherapy' Causing More Harm Than Good?Long-Term Antibiotic Use May Up Women's Odds for Heart TroubleSalmonella Outbreak Tied to Pre-Cut Melons Expands to More Than 100 CasesAs U.S. Measles Cases Hit New High, Experts Warn the Disease Can Be Deadly
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Over 2 Million Americans Have Hepatitis C; Opioids Help Drive Spread

HealthDay News
by By Amy Norton
HealthDay Reporter
Updated: Nov 6th 2018

new article illustration

TUESDAY, Nov. 6, 2018 (HealthDay News) -- More than 2 million Americans have hepatitis C -- and the opioid epidemic is a major contributor to the problem, according to a new government study.

The study, by the U.S. Centers for Disease Control and Prevention, does highlight progress against the potentially fatal liver disease. It also shows how much more work remains, CDC officials said.

Between 2013 and 2016, the agency estimated, nearly 2.4 million Americans had hepatitis C infections.

That's a small decline from previous years. And the CDC said that may indicate the effects of new therapies that have changed the face of hepatitis C treatment in the past several years.

But it's also likely that deaths among older Americans with the infection account for part of the decline, the agency added.

And while better treatment may be making a dent in hepatitis C cases, the new figures show that most Americans with the infection had not yet benefited by the end of 2016.

Meanwhile, there are ominous signs when it comes to hepatitis C prevention.

Earlier CDC research found that new hepatitis C cases tripled between 2010 and 2016. Most were traced to injection-drug use among younger adults addicted to heroin and other opioids. Adults under 40 have the highest rate of new infections.

"The opioid crisis is sabotaging our progress against hepatitis C," said the CDC's Dr. Jonathan Mermin, who worked on the new study.

Hepatitis C is a viral infection that causes inflammation in the liver. In most cases, the infection becomes chronic. Without treatment, about 15 percent to 30 percent of people with chronic hepatitis C will develop cirrhosis (scarring) of the liver, according to the CDC. Some of those also develop liver cancer.

These days, most people become infected by sharing injection-drug equipment, said Dr. Judith Feinberg, an infectious disease expert who was not involved in the study.

Baby boomers -- people born between 1945 and 1965 -- account for most hepatitis C cases in the United States. But the opioid crisis is putting a "whole new generation" of Americans at risk, said Feinberg, chairwoman-elect of the HIV Medicine Association.

Feinberg noted that West Virginia, which has been hard-hit by the opioid epidemic, has the nation's second-highest rate of acute hepatitis C infections.

It's a worrisome trend that has evolved at the same time as breakthroughs in chronic hepatitis C treatment, Feinberg said.

For decades, the only treatment for hepatitis C involved the injection drug interferon -- a year-long regimen that often caused fatigue and flu-like side effects. Even then, the cure rate was 40 percent to 50 percent, according to the U.S. Food and Drug Administration.

But in the past several years, new oral drugs to fight hepatitis C have been approved -- all with cure rates that top 90 percent after two or three months of treatment.

"We can cure it now, which is wonderful," Feinberg said.

The problem has been access to treatment, Mermin said. Many people who have hepatitis C don't know it, because they haven't been tested.

The CDC recommends testing for baby boomers and for anyone who has ever abused injection drugs, Mermin said.

Then there is the huge price tag of treatment. The first of the new drugs to hit the market -- including Sovaldi and Harvoni -- cost as much as $95,000 for a full round of treatment.

State Medicaid programs, which cover many Americans with hepatitis C, balked at the cost and set up restrictions, Feinberg said. Generally, only people with more-severe liver damage could get the drugs -- when it was too late to prevent hep C complications.

But shifts are taking place, Feinberg said. Increased competition is bringing costs down; the cost of a cure can be $15,000 to $25,000 now, she noted.

"A number of state Medicaid programs have moved to no restrictions, or looser restrictions," Feinberg said.

Ideally, though, hepatitis C should be prevented. Both Mermin and Feinberg pointed to "syringe service programs" as one strategy. The community programs offer injection-drug users clean equipment, to help prevent infections; they can also link people to drug abuse treatment and infection testing, Mermin said.

But a CDC study last year found that only three U.S. states have laws that "support full access" to both syringe service programs and hepatitis C treatment.

The new findings were published online Nov. 6 in the journal Hepatology.

More information

The CDC has more on hepatitis C.